Latin America mRNA Synthesis & Manufacturing Market (2024-2029)
The Latin America mRNA Synthesis & Manufacturing Market was valued at $30.06 Million in 2024 and projected to reach to $36.31 Million by 2029, representing a compound annual growth rate of CAGR 3.9%. Latin America's mRNA synthesis and manufacturing market is poised for steady expansion over the next five years, driven by growing biotechnology investments and regional capacity building initiatives.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Latin America mRNA Synthesis & Manufacturing Market Trends and Insights
- This represents a compound annual growth rate (CAGR) of 3.9% throughout the forecast period.
- Latin America is gradually establishing itself as a regional hub for mRNA production, driven by increasing investments in biotechnology infrastructure and growing demand for personalized medicine solutions across the region. The mRNA synthesis market in Latin America is characterized by emerging manufacturing capabilities and rising pharmaceutical partnerships.
- Latin America's growth trajectory, while more moderate than global markets, reflects the region's developing regulatory frameworks and expanding healthcare investments.
- By 2029, Latin America is expected to strengthen its position in the global mRNA supply chain, supported by government initiatives and private sector collaboration in countries such as Brazil, Mexico, and Argentina. Latin America's market expansion is underpinned by technological advancement and regional capacity building.
- Latin America continues to attract international biopharmaceutical companies seeking to diversify manufacturing locations and reduce supply chain risks, positioning the region as an increasingly important player in global mRNA production..
Key Market Statistics
- CAGR (2024-2029) CAGR 3.9%
- Market Size, 2024 ~USD 30.06 Million
- Forecast, 2029 ~USD 36.31 Million
- Geography Latin America
Latin America mRNA Synthesis & Manufacturing Market Overview
Regional Market Valuation :
Latin America's mRNA synthesis and manufacturing market is valued at $30.06 million in 2024, with projections to reach $36.31 million by 2029, demonstrating consistent regional growth.
Steady Growth Trajectory :
The region exhibits a CAGR of 3.9% during the forecast period, outpacing some mature markets while reflecting emerging market dynamics and increasing biotechnology adoption across Latin America.
Emerging Hub Development :
Latin America is gradually establishing itself as a regional production hub for mRNA manufacturing, supported by rising investments in biotechnology infrastructure and regulatory framework improvements.
Investment Momentum :
Increasing capital allocation toward mRNA production facilities and research initiatives across Latin American countries is driving market expansion and attracting international biotechnology partnerships.
Latin America mRNA Synthesis & Manufacturing Market Dynamics
- The region's CAGR of 3.9% reflects a maturing market with increasing adoption of mRNA technologies in vaccine development and therapeutic applications.
- Key drivers include government support for life sciences infrastructure, rising healthcare expenditures, and partnerships with global pharmaceutical companies seeking to diversify manufacturing locations. The forecast period will likely see Latin America strengthen its position as a secondary manufacturing hub for mRNA products, particularly for regional distribution.
- Enhanced regulatory frameworks, improved access to capital, and talent development in biotechnology will further accelerate market growth.
- However, competition from established manufacturing centers and infrastructure limitations may moderate growth rates compared to global averages, positioning Latin America as a strategic but emerging player in the global mRNA manufacturing landscape..
Related Ecosystem
Advanced Genetic Sequencing
- Polymerase Chain Reaction (PCR)
- Reagents
- Assay Kits
- Bioinformatics
- Flow Cytometry
- Thermo Fisher Scientific Inc.
- Illumina, Inc.
- Agilent Technologies, Inc.
- Qiagen N.V.
- Danaher Corporation
Analytical And Scientific Instrumentation
- Environmental Testing
- Gas Chromatography
- Polymerase Chain Reaction (PCR)
- Automated Liquid Handling Systems
- Flow Cytometry
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Agilent Technologies, Inc.
- Shimadzu Corporation
- Merck KGaA
Pharmaceuticals
- Bioreactors
- Analytical Testing
- Bioanalytical Testing Services
- Cell Counters
- Data Management Services
- Thermo Fisher Scientific Inc.
- SANOFI
- Merck KGaA
- NOVARTIS
- Pfizer Inc.
Key Takeaways
- Latin America's mRNA synthesis market is valued at $30.06 million in 2024 and is forecast to reach $36.31 million by 2029, growing at a 3.9% CAGR.
- Latin America is emerging as a regional manufacturing hub, with Brazil, Mexico, and Argentina leading investments in mRNA production infrastructure.
- Latin America's growth is driven by expanding healthcare demand, government biotechnology initiatives, and international pharmaceutical partnerships seeking supply chain diversification.
- Latin America's regulatory environment and technological capabilities are progressively strengthening, positioning the region for increased global mRNA supply chain participation.
mRNA Synthesis & Manufacturing Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | MRNA SYNTHESIS & MODIFICATION SERVICES (Service) |
| Forecast Period | 2024-2029 |
| Growth Rate | CAGR of 5.8% from 2024 to 2029 |
| Largest Segment | CONSUMABLES (Product) |
| Market Size Base Year (Billions) | ~USD 2.23 (2024) |
| Revenue Forecast (Billions) | ~USD 2.96 (2029) |
| Segments Covered | Product, Type, Application, End User, Service, Consumables, Transcription Consumables, Purification Consumables, Analysis & Characterization Consumables |
Latin America mRNA Synthesis & Manufacturing Market Report Segmentation
9 segment dimensions are covered across the global market.
By Product
- Consumables
- Instruments
By Type
- Analysis & Characterization Consumables
- Analysis Kits And Reagents
- Chromatography Filters & Membrane
- Mrna Profiling Kits
- Mrna Synthesis Kits
- Nucleotides
- Other Products
- Other Purification Consumables
- Other Transcription Consumables
- Plasmid Dna/Dna Templates
- Purification Consumables
- Purification Kits & Reagents
- Rna Polymerases
- Transcription Consumables
- Vectors
By Application
- Cell & Gene Therapies
- Other Applications
- Vaccines
By End User
- Academic & Research Institutions
- Cros & Cdmos
- Cros And Cdmos
- Pharmaceutical & Biotechnology Companies
- Small-Scale Cros & Cdmos
By Service
- Manufacturing & Scale-Up Services
- Mrna Analysis & Characterization Services
- Mrna Purification Services
- Mrna Synthesis & Modification Services
By Consumables
- Analysis & Characterization Consumables
- Purification Consumables
- Transcription Consumables
By Transcription Consumables
- Mrna Profiling Kits
- Mrna Synthesis Kits
- Nucleotides
- Other Transcription Consumables
- Plasmid Dna/Dna Templates
- Rna Polymerases
- Vectors
By Purification Consumables
- Chromatography Filters & Membranes
- Other Purification Consumables
- Purification Kits & Reagents
- Purification Kits And Reagents
By Analysis & Characterization Consumables
- Analysis Kits & Reagents
- Analysis Kits And Reagents
- Other Analysis & Characterization Consumables
Target Audience
- Pharmaceutical & Biotech Companies : Evaluate Latin America as a manufacturing and distribution hub for mRNA-based therapeutics and vaccines, with insights on regional capacity and market potential.
- Contract Manufacturing Organizations (CMOs) : Assess opportunities to establish or expand mRNA synthesis and manufacturing operations in Latin America to serve regional and global markets.
- Healthcare Investors & Private Equity : Identify investment opportunities in Latin American mRNA manufacturing infrastructure, biotech startups, and healthcare technology companies with growth potential.
- Government & Regulatory Bodies : Understand market trends and investment flows in Latin America's mRNA sector to inform policy decisions, incentive programs, and regulatory framework development.
- Healthcare Consultants & Analysts : Provide clients with authoritative regional market data, competitive analysis, and strategic recommendations for Latin America's mRNA manufacturing landscape.
Countries within Latin America - compare and drill down
| Country | 2025 size (native) |
|---|---|
| Brazil | USD 20.04 Million |
| Rest Of Latin America | USD 16.28 Million |
Country market size visualization
Reasons to Buy this Report
- Regional Market Intelligence : Gain comprehensive insights into Latin America's mRNA synthesis market dynamics, including country-level breakdowns, investment trends, and competitive landscape specific to the region.
- Growth Opportunity Identification : Identify emerging opportunities in Latin America's expanding mRNA manufacturing sector with detailed forecasts through 2029 and analysis of regional growth drivers.
- Strategic Expansion Planning : Support market entry and expansion strategies in Latin America with data-driven insights on regional capacity, regulatory environment, and investment requirements.
- Competitive Positioning : Benchmark your operations against regional competitors and understand Latin America's positioning relative to global mRNA manufacturing hubs.
- Investment Decision Support : Make informed investment decisions in Latin American mRNA facilities and partnerships with validated market sizing, growth projections, and regional opportunity assessments.
Frequently asked questions
What is the current market size of mRNA synthesis in Latin America?
Latin America's mRNA synthesis and manufacturing market was valued at $30.06 million in 2024 and is expected to grow to $36.31 million by 2029.
What is the projected growth rate for Latin America's mRNA market?
Latin America's mRNA synthesis market is projected to grow at a compound annual growth rate (CAGR) of 3.9% from 2024 to 2029.
Which countries in Latin America are leading mRNA manufacturing development?
Brazil, Mexico, and Argentina are the primary drivers of mRNA manufacturing growth in Latin America, supported by government initiatives and private sector investments.
What factors are driving growth in Latin America's mRNA market?
Latin America's mRNA market growth is driven by increasing biotechnology infrastructure investments, rising demand for personalized medicine, government support, and international pharmaceutical partnerships seeking manufacturing diversification.
How does Latin America's mRNA market growth compare to global trends?
Latin America's 3.9% CAGR is more moderate than the global market's 5.8% CAGR, reflecting the region's developing regulatory frameworks and emerging manufacturing capabilities.
RESEARCH METHODOLOGY
The study involved major activities in estimating the current market size for the mRNA synthesis and manufacturing market. Exhaustive secondary research was done to collect information on the mRNA synthesis and manufacturing industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as market share analysis, MnM repository analysis, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the mRNA synthesis and manufacturing market.
Secondary Research
The market for the companies offering mRNA synthesis and manufacturing solutions is arrived at by secondary data available through paid and unpaid sources, analyzing the product & service portfolios of the major companies in the ecosystem, and rating the companies by their performance and quality. Various sources were referred to in the secondary research process to identify and collect information for this study. The secondary sources include annual reports, press releases, investor presentations of companies, white papers, journals, certified publications, and articles from recognized authors, directories, and databases. In the secondary research process, various secondary sources were referred to for identifying and collecting information related to the study. Secondary sources included annual reports, press releases, and investor presentations of blockchain vendors, forums, certified publications, and whitepapers. The secondary research was used to obtain critical information on the industry’s value chain, the total pool of key players, market classification, and segmentation from the market and product-oriented perspectives.
Primary Research
Extensive primary research was conducted after acquiring basic knowledge about the global mRNA synthesis and manufacturing market scenario. Several primary interviews were conducted with market experts from both the demand side (such as personnel from the pharmaceutical & biopharmaceutical industry) and the supply side (such as C-level and D-level executives, product managers, marketing and sales managers of key manufacturers, distributors, as well as channels) across five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. Approximately 80% and 20% of primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, and online, personal, and telephonic interviews.
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Top-down approache was used to estimate and validate the total size of the mRNA synthesis and manufacturing market. These methods include market share analysis, MnM repository analysis were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry and market have been identified through extensive secondary research.
- The revenues generated from the mRNA synthesis and manufacturing market business of leading players have been determined through primary and secondary research.
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments.
Data Triangulation
After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable.
Market Definition
mRNA synthesis and manufacturing refers to the process of producing messenger RNA (mRNA) through in vitro transcription, followed by various purification, and characterization steps to create high-quality mRNA products suitable for research, therapeutic, or vaccine applications. The mRNA synthesis and manufacturing market encompasses the development, production, and commercialization of messenger RNA (mRNA) products, including their synthesis via in vitro transcription, large-scale manufacturing, and formulation. This market serves various applications such as vaccines, therapeutic treatments, and potentially other areas like protein replacement. It involves specialized technologies and equipment, adherence to regulatory standards, and a global supply chain network.
The study provides an in-depth analysis of the mRNA synthesis and manufacturing market based on contemporary market trends and developments, and its potential growth from 2024 to 2029. It includes detailed market trends, the competitive landscape, market size, forecasts, and the analysis of the key mRNA synthesis and manufacturing product and service providers.
Stakeholders
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Contract Development and Manufacturing Organizations (CDMOs)
- Raw Material Suppliers
- Market Research and Consulting Firms
- Regulatory Agencies
- Venture Capitalists
- Government Organizations
- Industry Associations and Professional Societies
Report Objectives
- To define, describe, and forecast the mRNA synthesis and manufacturing market based on product, service, application, and region
- To define, describe, and forecast the mRNA synthesis and manufacturing market based on product by end user and service by end user
- To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the mRNA synthesis and manufacturing market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six main regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
- To profile the key players in the global mRNA synthesis and manufacturing market and comprehensively analyze their products and services portfolios, market positions, and core competencies.
- To track and analyze competitive developments such as product/service launches, expansions, agreements, and collaborations in the mRNA synthesis and manufacturing market
- To benchmark players within the mRNA synthesis and manufacturing market using the Company Evaluation Matrix framework, which analyzes market players based on various parameters within the broad categories of business and service strategy
Get the Full mRNA Synthesis & Manufacturing Market Report
Full forecast, segment splits, and company analysis for all mRNA Synthesis & Manufacturing Market.
- Canada mRNA Synthesis & Manufacturing Market
- US mRNA Synthesis & Manufacturing Market
- Germany mRNA Synthesis & Manufacturing Market
- UK mRNA Synthesis & Manufacturing Market
- France mRNA Synthesis & Manufacturing Market
- Switzerland mRNA Synthesis & Manufacturing Market
- Italy mRNA Synthesis & Manufacturing Market
- Spain mRNA Synthesis & Manufacturing Market
- China mRNA Synthesis & Manufacturing Market
- Japan mRNA Synthesis & Manufacturing Market
- India mRNA Synthesis & Manufacturing Market
- South Korea mRNA Synthesis & Manufacturing Market
- Brazil mRNA Synthesis & Manufacturing Market
- Rest Of Europe mRNA Synthesis & Manufacturing Market
- Rest Of Asia Pacific mRNA Synthesis & Manufacturing Market
- Rest Of Latin America mRNA Synthesis & Manufacturing Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
